CODA Biotherapeutics Company
CODA Biotherapeutics is developing a novel chemogenetic platform to modulate neuronal activity.
Industry:
Gene Therapy
Technology:
Others
Headquarters:
South San Francisco, California, United States
Founded Date:
2014
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M